XML 26 R17.htm IDEA: XBRL DOCUMENT
v3.23.1

FAIR VALUE OF FINANCIAL INSTRUMENTS | 3 Months Ended
--- | ---
Mar. 31, 2023
Fair Value Disclosures [Abstract] |
FAIR VALUE OF FINANCIAL INSTRUMENTS | FAIR VALUE OF FINANCIAL INSTRUMENTS Forward Foreign Exchange and Currency Option Contracts The Corporation has foreign currency exposure, primarily against the British Pound, Euro, and Canadian dollar. The Corporation uses financial instruments, such as forward and option contracts, to hedge a portion of existing and anticipated foreign currency denominated transactions. The purpose of the Corporation’s foreign currency risk management program is to reduce volatility in earnings caused by exchange rate fluctuations. Guidance on accounting for derivative instruments and hedging activities requires companies to recognize all of the derivative financial instruments as either assets or liabilities at fair value in the Condensed Consolidated Balance Sheets based upon quoted market prices for comparable instruments. Interest Rate Risks and Related Strategies The Corporation’s primary interest rate exposure results from changes in U.S. dollar interest rates. The Corporation’s policy is to manage interest cost using a mix of fixed and variable rate debt. Effects on Condensed Consolidated Balance Sheets As of March 31, 2023 and December 31, 2022, the fair values of the asset and liability derivative instruments were immaterial. Effects on Condensed Consolidated Statements of Earnings Undesignated hedges The losses and gains and on forward exchange derivative contracts not designated for hedge accounting are recognized to general and administrative expenses within the Condensed Consolidated Statements of Earnings. The gain for the three months ended March 31, 2023 was $4 million. The loss for the three months ended March 31, 2022 was immaterial. Debt The estimated fair value amounts were determined by the Corporation using available market information that is primarily based on quoted market prices for the same or similar issuances as of March 31, 2023. Accordingly, all of the Corporation’s debt is valued as a Level 2 financial instrument. The fair values described below may not be indicative of net realizable value or reflective of future fair values. Furthermore, the use of different methodologies to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.
| March 31, 2023 |  | December 31, 2022
(In thousands) | Carrying Value |  | Estimated Fair Value |  | Carrying Value |  | Estimated Fair Value
Revolving credit agreement, due 2027 | $ | 178,200 |  |  | $ | 178,200 |  |  | $ | — |  |  | $ | — |
3.70% Senior notes due 2023 | — |  |  | — |  |  | 202,500 |  |  | 202,082 |
3.85% Senior notes due 2025 | 90,000 |  |  | 88,331 |  |  | 90,000 |  |  | 87,298 |
4.24% Senior notes due 2026 | 200,000 |  |  | 195,529 |  |  | 200,000 |  |  | 191,760 |
4.05% Senior notes due 2028 | 67,500 |  |  | 64,926 |  |  | 67,500 |  |  | 63,300 |
4.11% Senior notes due 2028 | 90,000 |  |  | 86,338 |  |  | 90,000 |  |  | 83,955 |
3.10% Senior notes due 2030 | 150,000 |  |  | 131,958 |  |  | 150,000 |  |  | 127,429 |
3.20% Senior notes due 2032 | 150,000 |  |  | 128,166 |  |  | 150,000 |  |  | 123,656 |
4.49% Senior notes due 2032 | 200,000 |  |  | 189,022 |  |  | 200,000 |  |  | 183,007 |
4.64% Senior notes due 2034 | 100,000 |  |  | 93,730 |  |  | 100,000 |  |  | 90,341 |
Total debt | 1,225,700 |  |  | 1,156,200 |  |  | 1,250,000 |  |  | 1,152,828 |
Debt issuance costs, net | (1,705) |  |  | (1,705) |  |  | (1,631) |  |  | (1,631) |
Unamortized interest rate swap proceeds | 5,624 |  |  | 5,624 |  |  | 6,031 |  |  | 6,031 |
Total debt, net | $ | 1,229,619 |  |  | $ | 1,160,119 |  |  | 1,254,400 |  |  | 1,157,228 |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration